Skip to Content
Merck
  • Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.

Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.

Scientific reports (2017-09-20)
Brian York, Feng Li, Fumin Lin, Kathrina L Marcelo, Jianqiang Mao, Adam Dean, Naomi Gonzales, David Gooden, Suman Maity, Cristian Coarfa, Nagireddy Putluri, Anthony R Means
PMID28924233
ABSTRACT

Binding of calcium to its intracellular receptor calmodulin (CaM) activates a family of Ca